Robert Bals
Experienced in Allergic Conjunctivitis

Robert Bals

Kirrberger Str. 100, 
Homburg, SL, DE 
Experienced in Allergic Conjunctivitis
Kirrberger Str. 100, 
Homburg, SL, DE 
OverviewLocationsClinical Research

Overview

Robert Bals practices in Homburg, Germany. Mr. Bals is rated as an Experienced expert by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Subcutaneous Emphysema, Lung Transplant, and Stent Placement.

His clinical research consists of co-authoring 306 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Allergic Conjunctivitis.

Gender
Male

Locations

Kirrberger Str. 100, Homburg, SL 66421, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Biological, Other
Study Drug: Prolastin C
Study Phase: Phase 3
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Drug, Device
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Dose-Escalating, Phase 1 Study to Determine the Safety, Tolerability, Pharmacokinetics and Effect of Circulating Alpha-1 Antitrypsin Levels of ARC-AAT in Healthy Volunteer Subjects and in Patients With Alpha-1 Antitrypsin Deficiency (AATD)
A Double-Blind, Placebo-Controlled, Dose-Escalating, Phase 1 Study to Determine the Safety, Tolerability, Pharmacokinetics and Effect of Circulating Alpha-1 Antitrypsin Levels of ARC-AAT in Healthy Volunteer Subjects and in Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Enrollment Status: Terminated
Publish Date: August 03, 2018
Intervention Type: Other, Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

304 Total Publications

Salvage extracorporeal membrane oxygenation in severe pulmonary haemorrhage: A single-center retrospective observational study.
Salvage extracorporeal membrane oxygenation in severe pulmonary haemorrhage: A single-center retrospective observational study.
Journal: Perfusion
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bals's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile